Not all leaders are good leaders.Perhaps you’ve lost an important executive or you’re establishing a local leadership team. You know that the leader you choose will have a major impact on the organization. So how can you avoid hiring the…
HOME > REGULATORY
REGULATORY
- Number of Diseases Eligible for Medical Aid Would Increase to Over 300 Under New Proposal
November 1, 2012
- RMP to Be Made Available through the Internet During Review Stage: Director Tawaragi of PFSB
October 30, 2012
- MHLW Earmarks 200 Mil. Yen for Drug Quality Assurance and Development of New Vaccine Quality Test Methods as Part of Emergency Economic Measures
October 30, 2012
- Japan Adopts Emergency Economic Package, 3.8 Billion Yen Front-Loaded for iPS Research, Drug Discovery Support
October 30, 2012
- PAFSC’s 1st Committee Recommends Approval for Pfizer’s OAB Drug Toviaz
October 29, 2012
- DPJ Vice President Sengoku Says JMA “Paranoid” over TPP Concerns
October 29, 2012
- Keidanren, JCCI Call for Expansion of R&D Tax Break System at Tax Commission Hearings
October 29, 2012
- Number of Pharmacies in Japan Rises to 54,780 as of FY2011 End: MHLW
October 29, 2012
- MHLW Unveils Action Plan for 5-Year Clinical Trial Activation Plan
October 26, 2012
- MHLW to Initially Limit Number of Stores to Offer Epadel OTC
October 26, 2012
- US Paperwork Reduction Act Will Not Affect ICH PBRER Guidelines: MHLW
October 26, 2012
- BBPD to Seek Reductions in Market Prices of Domestic Blood Products: New BBPD Director Kato
October 26, 2012
- Basic Bill for Regenerative Medicine to Be Submitted to Extraordinary Diet by Bipartisan Lawmaker-Initiated Legislation
October 26, 2012
- METI and MEXT Call for Increase in R&D Tax Credit
October 25, 2012
- Generic-Only Requirement for People on Welfare “Would Be Problematic”: Health Minister Mitsui
October 24, 2012
- MOF Asks Committee to Discuss Mandatory Generic Drug Use for People on Welfare
October 24, 2012
- MHLW Project to Study Generic Evaluation Criteria Gets Underway
October 23, 2012
- Health Minister Mitsui Pledges Seamless Support for New Drug Development
October 22, 2012
- Sales Tax Hike Expected to Hasten Separation of Dispensing from Medical Practice by Sapping Yakka-Saeki
October 19, 2012
- FSA to Determine Whether Infertility Treatment Should Be Covered by Private Insurers
October 19, 2012
ページ
Earlier this month, Health Minister Keizo Takemi called on the top executives of 13 major generic makers to restructure the industry with a product consolidation target of “around five companies per API.” While a variety of restructuring options are conceivable,…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…